Skip to main content
TipRanks
Go Ultimate75% OFF

GlaxoSmithKline (GSK) Ownership - Who Owns GlaxoSmithKline?

5,274 Followers

GlaxoSmithKline (GSK) Ownership Overview

The ownership structure of GlaxoSmithKline (GSK) stock is a mix of institutional, retail, and individual investors. Approximately 13.51% of the company’s stock is owned by Institutional Investors, and 86.49% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Sep 30, 2026Tweedy Browne Co Llc$3,730,237
Sep 30, 2026Gallacher Capital Management Llc$267,922
Sep 30, 2026Dodge & Cox$2,080,130,746
Sep 30, 2026Hotchkis & Wiley Capital Management Llc$188,785,985

Top Shareholders

GSK top shareholders
Holder# of SharesType% HoldingValue
John A. Gunn43,183,117Institution2.13%2,178,588,253
Dodge & Cox Funds39,174,382Institution1.94%1,976,347,572
Ken Fisher35,351,693Institution1.75%1,783,492,912
Theofanis Kolokotrones25,192,138Institution1.25%1,270,943,362
Vanguard Chester Funds18,172,650Institution0.90%916,810,193
Vanguard Wellington Fund9,498,942Institution0.47%479,221,624
Fidelity Rutland Square Trust Ii8,522,636Institution0.42%429,966,986
Fidelity Hastings Street Trust5,642,694Institution0.28%284,673,912
Fidelity Devonshire Trust4,136,200Institution0.20%208,671,290
Fidelity Securities Fund3,556,375Institution0.18%179,419,119

Top Mutual Fund Holders

GSK top mutual fund holders
Holder# of SharesType% HoldingValue
Dodge & Cox Funds39,174,382Institution1.94%1,976,347,572
Vanguard Chester Funds18,172,650Institution0.90%916,810,193
Vanguard Wellington Fund9,498,942Institution0.47%479,221,624
Fidelity Rutland Square Trust Ii8,522,636Institution0.42%429,966,986
Fidelity Hastings Street Trust5,642,694Institution0.28%284,673,912
Fidelity Devonshire Trust4,136,200Institution0.20%208,671,290
Fidelity Securities Fund3,556,375Institution0.18%179,419,119
Vanguard Fenway Funds3,549,080Institution0.18%179,051,086
Fidelity Financial Trust2,697,200Institution0.13%136,073,740
T. Rowe Price International Funds, Inc.2,639,571Institution0.13%133,166,357

Top ETF Holders

GSK top ETF holders
Holder# of SharesType% HoldingValue
Avantis International Equity ETF, AVDE ETF1,474,737Institution0.07%74,680,682
Fidelity Enhanced International ETF, FENI ETF956,949Institution0.05%48,278,077
VanEck Pharmaceutical ETF, PPH ETF909,450Institution0.04%46,054,548
First Trust Value Line Dividend Index Fund, FVD ETF647,351Institution0.03%32,658,858
Hartford Multifactor Developed Markets (ex-US) ETF, RODM ETF307,034Institution0.02%15,548,202
GMO International Value ETF, GMOI ETF291,592Institution0.01%14,634,470
Dimensional World ex U.S. Core Equity 2 ETF, DFAX ETF276,647Institution0.01%14,009,404
Avantis International Large Cap Value ETF, AVIV ETF254,181Institution0.01%12,871,726
Brandes International ETF, BINV ETF188,600Institution<0.01%9,514,870
T. Rowe Price International Equity ETF, TOUS ETF161,105Institution<0.01%8,253,409

FAQ

What percentage of GlaxoSmithKline (GSK) stock is held by institutional investors?
According to the latest TipRanks data, approximately 13.51% of GlaxoSmithKline (GSK) stock is held by institutional investors: 5.87% by mutual funds, 0.34% by ETFs and 7.30% by other institutional investors.
What percentage of GlaxoSmithKline (GSK) stock is held by retail investors?
According to the latest TipRanks data, approximately 86.49% of GlaxoSmithKline (GSK) stock is held by public companies and individual investors.
Who owns the most shares of GlaxoSmithKline (GSK)?
John A. Gunn owns the most shares of GlaxoSmithKline (GSK).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.